Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
SLM Corp
SLM
$4.83B
| $44.8M | 0.04% |
4,774,560
-131,462
| -3% | -$1.21M |
|
327
Bankunited
BKU
$3.33B
| $44.8M | 0.04% |
1,360,456
+480,360
| +55% | +$15.3M |
|
328
Freeport-McMoran
FCX
$86.2B
| $44.7M | 0.04% |
1,185,445
-31,657
| -3% | -$1.12M |
|
329
Crane NXT
CXT
$2.99B
| $44.6M | 0.04% |
1,910,542
+500,157
| +35% | +$11M |
|
330
Home Depot
HD
$337B
| $44.5M | 0.04% |
540,500
-263,188
| -33% | -$20.5M |
|
331
The GEO Group
GEO
$4B
| $44.4M | 0.04% |
2,068,596
+122,241
| +6% | +$2.74M |
|
332
Portland General Electric
POR
$5.82B
| $44.4M | 0.04% |
1,470,241
+278,649
| +23% | +$8.19M |
|
|
MWE
333
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $44.4M | 0.04% |
670,995
+1,912
| +0.3% | +$133K |
|
334
Bank of America
BAC
$429B
| $44M | 0.04% |
2,823,565
-3,828
| -0.1% | -$56.8K |
|
335
United Natural Foods
UNFI
$3.04B
| $43.6M | 0.04% |
577,808
-319,085
| -36% | -$22.5M |
|
336
Plains GP Holdings
PAGP
$5.28B
| $43.5M | 0.04% |
+610,773
| New | +$38.2M |
|
|
EXPR
337
DELISTED
Express, Inc.
EXPR
| $43.5M | 0.04% |
116,487
-25,869
| -18% | -$11.4M |
|
338
Bruker
BRKR
$9.4B
| $43.2M | 0.04% |
2,183,678
+291,986
| +15% | +$5.73M |
|
|
TLM
339
DELISTED
TALISMAN ENERGY INC
TLM
| $42.7M | 0.04% |
3,663,624
-95,774
| -3% | -$1.15M |
|
340
Puma Biotechnology
PBYI
$398M
| $42.4M | 0.04% |
409,665
-321,846
| -44% | -$18.9M |
|
|
PF
341
DELISTED
Pinnacle Foods, Inc.
PF
| $42M | 0.04% |
1,531,134
+155,375
| +11% | +$4.22M |
|
|
SN
342
DELISTED
Sanchez Energy Corporation
SN
| $41.9M | 0.04% |
1,710,208
-451,209
| -21% | -$12M |
|
343
Commault Systems
CVLT
$4.98B
| $41.9M | 0.04% |
559,145
-27,614
| -5% | -$2.16M |
|
|
PPO
344
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $41.6M | 0.04% |
1,069,423
-63,485
| -6% | -$2.5M |
|
345
Teva Pharmaceuticals
TEVA
$40.4B
| $41.2M | 0.04% |
1,028,828
-4,106
| -0.4% | -$162K |
|
346
Pembina Pipeline
PBA
$29.3B
| $41.1M | 0.04% |
1,165,906
-491,307
| -30% | -$16.1M |
|
|
WR
347
DELISTED
Westar Energy Inc
WR
| $41M | 0.04% |
1,273,792
-248,396
| -16% | -$7.84M |
|
|
MXIM
348
DELISTED
Maxim Integrated Products
MXIM
| $40.4M | 0.04% |
1,446,975
-42,211
| -3% | -$1.22M |
|
|
CLNY
349
DELISTED
Colony Capital, Inc.
CLNY
| $39.9M | 0.04% |
1,967,968
-74,214
| -4% | -$1.5M |
|
|
NFX
350
DELISTED
Newfield Exploration
NFX
| $39.9M | 0.04% |
1,619,914
-2,096,157
| -56% | -$58.8M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.